EP 0473707 A4 19921209 - INJECTABLE CLARITHROMYCIN COMPOSITION
Title (en)
INJECTABLE CLARITHROMYCIN COMPOSITION
Publication
Application
Priority
US 35828389 A 19890526
Abstract (en)
[origin: WO9014094A1] An injectable drug composition is provided for intravenous or intramuscular administration which comprises a therapeutically effective concentration of clarithromycin, and a triglyceride oil and a stabilizing agent.
IPC 1-7
IPC 8 full level
C10C 3/00 (2006.01); A61K 9/107 (2006.01); A61K 31/00 (2006.01); A61K 31/70 (2006.01); A61K 31/7042 (2006.01); A61K 31/7048 (2006.01); A61K 47/12 (2006.01); A61K 47/14 (2006.01); A61K 47/22 (2006.01); A61K 47/44 (2006.01); A61P 31/00 (2006.01); A61P 31/04 (2006.01); C07H 17/08 (2006.01); C10C 3/06 (2006.01); D01F 9/155 (2006.01)
CPC (source: EP KR)
A61K 9/0019 (2013.01 - EP); A61K 9/1075 (2013.01 - EP); A61K 31/70 (2013.01 - EP KR); A61K 47/12 (2013.01 - EP); A61K 47/14 (2013.01 - EP); A61K 47/22 (2013.01 - EP); A61K 47/44 (2013.01 - EP); A61P 31/00 (2017.12 - EP); A61P 31/04 (2017.12 - EP); C10C 3/002 (2013.01 - EP); C10C 3/06 (2013.01 - EP); D01F 9/155 (2013.01 - EP)
Citation (search report)
- [Y] EP 0302370 A1 19890208 - ABBOTT LAB [US]
- [YP] EP 0361928 A2 19900404 - SHISEIDO CO LTD [JP]
- See references of WO 9014094A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB IT LI LU NL SE
DOCDB simple family (publication)
WO 9014094 A1 19901129; AU 5811090 A 19901218; AU 630469 B2 19921029; CA 2056445 A1 19901127; EP 0473707 A1 19920311; EP 0473707 A4 19921209; GR 1002177 B 19960307; GR 900100402 A 19911010; IL 94516 A0 19910310; IL 94516 A 19941229; JP 2963537 B2 19991018; JP H04505762 A 19921008; KR 920700655 A 19920810; NZ 233827 A 19910625
DOCDB simple family (application)
US 9003063 W 19900525; AU 5811090 A 19900525; CA 2056445 A 19900525; EP 90909022 A 19900525; GR 900100402 A 19900528; IL 9451690 A 19900527; JP 50856190 A 19900525; KR 910701690 A 19911126; NZ 23382790 A 19900525